NPM1 and acute myeloid leukemia: OCI-AML-3 cells harbor mutation of the nucleolar protein nucleophosmin 1 (NPM1), reported in approximately 30–35% AML cases, leading to its aberrant cytoplasmatic localization [16,17,18].